Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain in the United States, Europe, and Australia. It offers Senza system, a spinal cord stimulation system that delivers its proprietary HF10 therapy. The company sells its products through its direct sales force, and a network of sales agents and independent distributors.
Take a look at the 1-year chart of Nevro (NYSE: NVRO) below with my added notations:
NVRO is been running higher for the past 2 months, while also confirming a key level of resistance to watch at $70 (red). NVRO has already tested that level several times over the past couple of weeks, and that level was also a resistance back in January. A break above that $70 level will lead to a test of the 52-week high, and most likely mean hitting new ones as well.
Join our new Linkedin Group by clicking the link below:
The Tale of the Tape: NVRO has a key level of resistance at $70. A long trade could be entered on a break through that level. However, if you are bearish on the stock, a short trade could be made on any rallies up to $70.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Christian Tharp, CMT
Follow me on Twitter: @cmtstockcoach